We are committed to serving the best interests of our shareholders. The investor pages that follow are your resource for financial information about Catalyst Biosciences, Inc.
NASDAQ: CBIO$10.330.03 (0.29%)Aug 17, 20184:00 p.m. ET
Delayed at least 15 minutes
Data provided by Nasdaq. Minimum 15 minutes delayed.
Press ReleasesAugust 15, 2018Catalyst Biosciences Announces Updated Positive Interim Data at the 2018 Hemophilia Drug Development SummitAugust 13, 2018Catalyst Biosciences Announces Oral Presentation at the 2018 Hemophilia Drug Development SummitAugust 02, 2018Catalyst Biosciences Reports Second Quarter Operating & Financial Results and Provides Corporate UpdateView all press releases »
Reverse Stock Split
|For the 1 for 15 Reverse Stock Split Tax Form, click here|
Targacept Special Dividend
|For the FAQ and additional information, click here.|
Catalyst Biosciences, Inc.
|Josephine Belluardo, Ph.D.|
LifeSci Public Relations